155 related articles for article (PubMed ID: 1734947)
1. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2.
Reiter Z; Ozes ON; Blatt LM; Taylor MW
J Immunother (1991); 1992 Jan; 11(1):40-9. PubMed ID: 1734947
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
Reiter Z; Tomson S; Ozes ON; Taylor MW
Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405
[TBL] [Abstract][Full Text] [Related]
3. A dual anti-tumor effect of a combination of interferon-alpha or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicity.
Reiter Z; Ozes ON; Blatt LM; Taylor MW
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):103-11. PubMed ID: 1370257
[TBL] [Abstract][Full Text] [Related]
4. An interferon resistant variant of the hairy-cell leukemic cell line, Eskol: biochemical and immunological characterization.
Ozes ON; Klein SB; Reiter Z; Taylor MW
Leuk Res; 1993 Nov; 17(11):983-90. PubMed ID: 7694002
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 2 protects hairy leukemic cells from lymphokine-activated killer cell-mediated cytotoxicity.
Reiter Z; Taylor MW
Cancer Res; 1993 Aug; 53(15):3555-60. PubMed ID: 7687924
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-induced enhancement of the susceptibility of hairy cell leukaemia lymphocytes to natural killer cell lysis.
Cordingley FT; Hoffbrand AV; Brenner MK
Br J Haematol; 1988 Sep; 70(1):37-41. PubMed ID: 3140887
[TBL] [Abstract][Full Text] [Related]
8. Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.
Liberati AM; De Angelis V; Fizzotti M; Schippa M; Cecchini M; Adiuto D; Di Clemente F; Palmisano L; Micozzi E; Zuccaccia M
Cancer Immunol Immunother; 1994 May; 38(5):323-31. PubMed ID: 7512888
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha 2b and vesnarinone influence levels of tumor necrosis factor-alpha, apoptosis, or interleukin 6 in ESKOL, a hairy cell leukemic cell line. A potential cytokine and oncogene relationship regulating apoptosis is suggested.
Khalaf W; Maina C; Byers J; Harvey W
Leuk Res; 2002 Feb; 26(2):169-77. PubMed ID: 11755467
[TBL] [Abstract][Full Text] [Related]
10. Interferon--a major regulator of natural killer cell-mediated cytotoxicity.
Reiter Z
J Interferon Res; 1993 Aug; 13(4):247-57. PubMed ID: 7693829
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
[TBL] [Abstract][Full Text] [Related]
12. Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events.
Trentin L; Ambrosetti A; Zambello R; Agostini C; Masciarelli M; Vinante F; Chilosi M; Pizzolo G; Cetto G; Semenzato G
Leuk Res; 1987; 11(9):843-7. PubMed ID: 3499539
[TBL] [Abstract][Full Text] [Related]
13. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z
Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
[TBL] [Abstract][Full Text] [Related]
14. Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.
Griffiths SD; Cawley JC
Leukemia; 1988 Jun; 2(6):377-81. PubMed ID: 3374170
[TBL] [Abstract][Full Text] [Related]
15. Lymphokine-activated killer cell functions in patients with leukemic B-lymphoproliferative diseases.
van der Harst D; Brand A; van Luxemburg-Heys SA; Kooy-Winkelaar EM; van Rood JJ
Blood; 1989 Nov; 74(7):2464-70. PubMed ID: 2804374
[TBL] [Abstract][Full Text] [Related]
16. Hairy cell leukemia cells are relatively NK-insensitive targets.
Starling GC; Nimmo JC; Hart DN
Pathology; 1988 Oct; 20(4):361-5. PubMed ID: 2977221
[TBL] [Abstract][Full Text] [Related]
17. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
18. Discordant effect of interferon on natural killer activity and tumor cell sensitivity to lysis in hairy cell leukemia.
Lahat N; Aghai E; Kotler A; Kinarty A; Sobel E; Gruener N; Froom P
Blood; 1988 Apr; 71(4):1141-3. PubMed ID: 3258536
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: a model for oncogene regulation and late B-cell differentiation.
Harvey W; Srour EF; Turner R; Carey R; Maze R; Starrett B; Kanagala R; Pereira D; Merchant P; Taylor M
Leuk Res; 1991; 15(8):733-44. PubMed ID: 1895754
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
Trentin L; Zambello R; Agostini C; Ambrosetti A; Chisesi T; Raimondi R; Bulian P; Pizzolo G; Semenzato G
Blood; 1990 Apr; 75(7):1525-30. PubMed ID: 2317560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
